IBA, a provider of proton therapy solutions for the treatment of cancer, has announced the delivery and installation of the Cyclone 230 for a new proton therapy center in Dimitrovgrad (Ulyanovsky region, Russia). The center will be a part of the Federal High-Tech Center of Medical Radiology of the Federal Medico-Biological Agency of Russia (FMBA).
IBA will equip the centre with the ProteusPLUS* four-treatment room configuration, which provides the best in class treatment with image-guided intensity-modulated proton therapy (IMPT). The installation of the facility started in August 2016. The acceptance of the first treatment room is planned for the end of 2017. The proton therapy center in Dimitrovgrad will be IBA’s first in the Russian Federation and is expected to treat up to 1,200 patients per year. The head of FMBA, Vladimir Uiba, governor of Ulaynovsky region, Sergey Morozov, and local media attended the event for IBA, FMBA and Russia. Representing IBA was vice president and the director of the IBA’s Representative office in Russia, CIS Kirill Makarenko, as well as the wider IBA site team.
“This is a historical event not only for the Ulyanovsky region but also for the whole country,” said Uiba. “The proton therapy technology produced by IBA is ground-breaking and highly praised also by the scientists and specialists in the Joint Institute of Nuclear Research in Dubna. Proton therapy is a unique method for cancer treatment and it is at the cutting edge of innovation in oncology.”
Kirill Makarenko, vice president of IBA and director of the IBA’s representative office in Russia, said: “There are around 500,000 new cancer cases diagnosed in Russia every year and many of them could be treated with proton therapy. The center in Dimitrovgrad will be the first of its kind available to cancer patients from the Ulyanovsky region and the whole Privolzhsky Federal District.”
* ProteusPLUS is the brand name of a Proteus235 configuration.Back To Top
IBA equips first proton therapy center in Russia. Appl Rad Oncol.